For the Quarter Ending December 2025
APAC
• In China, the Magnesium Acetate Tetrahydrate Price Index rose by 1.45% quarter-over-quarter, reflecting tighter demand.
• The average Magnesium Acetate Tetrahydrate price for the quarter was approximately USD 1071.67/MT, reported officially.
• Magnesium Acetate Tetrahydrate Spot Price remained muted as exporters cleared inventory, pressuring the Price Index.
• Magnesium Acetate Tetrahydrate Production Cost Trend showed pressure from acetic acid increases, supporting firmer offers.
• Magnesium Acetate Tetrahydrate Demand Outlook remains cautious as formulators work down inventories, delaying incremental procurement.
• Magnesium Acetate Tetrahydrate Price Forecast indicates range-bound upside, supported by environmental audits and de-icing demand.
• Coastal plants' high utilisation maintained supply, export enquiries sustained the Price Index and prevented downside.
• Inventories at coastal warehouses rose modestly, constraining spot rallies despite balanced trade and feedstock inflows.
Why did the price of Magnesium Acetate Tetrahydrate change in December 2025 APAC?
• Environmental audits idled small northern units, reducing spot availability and tightening exportable balances during December.
• Acetic acid input firming lifted conversion costs, enabling exporters to pass through upward price pressure.
• Seasonal de-icing and pharma call-offs strengthened demand, while export logistics remained functional, supporting prompt shipments.
Europe
• In Europe, the Magnesium Acetate Tetrahydrate Price Index increased modestly on a quarter-over-quarter basis, reflecting steady seasonal demand and controlled availability.
• The average Magnesium Acetate Tetrahydrate price for the quarter was estimated at approximately USD 1,120.00/MT, based on CFR assessments across key European markets.
• Magnesium Acetate Tetrahydrate Spot Price movements remained range-bound as distributors balanced fresh arrivals against cautious buyer pull.
• Magnesium Acetate Tetrahydrate Production Cost Trend showed upward bias due to firmer acetic acid pricing and energy-related processing expenses.
• Magnesium Acetate Tetrahydrate Demand Outlook stayed cautious, as pharmaceutical and specialty chemical buyers relied on existing inventories.
• Magnesium Acetate Tetrahydrate Price Forecast pointed to limited upside, supported by winter de-icing applications and compliance-driven supply discipline.
• Imports and domestic production maintained overall supply balance, preventing sharp Price Index volatility.
• Warehouse inventories remained comfortable, constraining spot-market rallies despite stable downstream demand.
Why did the price of Magnesium Acetate Tetrahydrate change in December 2025 in Europe?
• Seasonal de-icing demand lifted short-term procurement, tightening availability marginally.
• Higher acetic acid input costs supported firmer supplier offers.
• Adequate inventories and predictable supply flows capped volatility, limiting the extent of price increases.
North America
• In North America, the Magnesium Acetate Tetrahydrate Price Index edged higher quarter-over-quarter, reflecting seasonal demand strength.
• The average Magnesium Acetate Tetrahydrate price for the quarter was approximately USD 1,150.00/MT, based on CFR U.S. market assessments.
• Magnesium Acetate Tetrahydrate Spot Prices remained largely stable, with suppliers resisting discounts amid steady offtake.
• Magnesium Acetate Tetrahydrate Production Cost Trend reflected upward pressure from firmer acetic acid costs and energy inputs.
• Magnesium Acetate Tetrahydrate Demand Outlook improved modestly as de-icing and pharmaceutical requirements increased toward winter.
• Magnesium Acetate Tetrahydrate Price Forecast suggested range-bound movement with mild upside bias, supported by winter demand.
• Domestic production and imports ensured adequate supply coverage, preventing supply-side shocks.
• Distributor inventories declined slightly in December, lending support to the Magnesium Acetate Tetrahydrate Price Index.
Why did the price of Magnesium Acetate Tetrahydrate change in December 2025 in North America?
• Seasonal de-icing demand increased call-offs, tightening near-term availability.
• Higher acetic acid and processing costs limited supplier willingness to discount.
• Stable supply continuity and inventory buffers prevented abrupt price spikes, keeping movements orderly.
For the Quarter Ending September 2025
North America
• In the United States and Canada, the Magnesium Acetate Tetrahydrate Price Index rose by ~3.0% quarter-over-quarter, supported by replenishment from pharmaceutical and nutraceutical sectors.
• The average Magnesium Acetate Tetrahydrate price for the quarter was approximately USD 1,055/MT for CFR East Coast North America imports (conservative estimate based on regional spreads).
• Magnesium Acetate Tetrahydrate Spot Price held firm as exporters reduced discounts and distributors had initiated restocking ahead of autumn production cycles.
• Magnesium Acetate Tetrahydrate Demand Outlook remains steady with programmatic pharmaceutical demand and growing nutraceutical orders supporting volumes.
• Magnesium Acetate Tetrahydrate Production Cost Trend eased as acetic acid prices softened, containing cost pressure for North American processors.
• Magnesium Acetate Tetrahydrate Price Forecast indicates modest firmness into Q4 as inventories draw down and procurement activity resumes.
• Regular import arrivals, stable inland logistics and responsive distributor replenishment supported orderly market activation and limited volatility.
• Export inquiries and domestic restocking tightened spot availability, allowing sellers to keep offers firmer compared with prior months.
Why did the price of Magnesium Acetate Tetrahydrate change in September 2025 in North America?
• Distributor and pharmaceutical restocking reduced on-hand inventories, increasing near-term demand and firming spot pricing.
• Softer acetic acid feedstock costs lowered production pressure, enabling maintained output and firmer offers.
• Efficient logistics and consistent import volumes prevented supply disruptions, so price moves were driven mainly by inventories and replenishment.
APAC
• In China, the Magnesium Acetate Tetrahydrate Price Index rose by 2.89% quarter-over-quarter, reflecting steady production.
• The average Magnesium Acetate Tetrahydrate price for the quarter was approximately USD 1056.33/MT during reporting.
• Magnesium Acetate Tetrahydrate Spot Price held firm as exporters trimmed discounts amid predictable procurement schedules.
• Magnesium Acetate Tetrahydrate Demand Outlook remains steady with pharmaceutical and nutraceutical offtake sustaining export volumes.
• Magnesium Acetate Tetrahydrate Production Cost Trend eased as acetic acid softened, reducing producer margin pressure.
• Magnesium Acetate Tetrahydrate Price Forecast suggests upward bias as inventories draw down and restocking begins.
• Magnesium Acetate Tetrahydrate Price Index reflects tighter spot availability and firmer exporter offers amid inquiries.
• Inventory drawdowns, efficient logistics, and steady pharma demand supported firmer Magnesium Acetate Tetrahydrate Price Index.
Why did the price of Magnesium Acetate Tetrahydrate change in September 2025 in APAC?
• Restocking by domestic pharmaceutical buyers reduced inventories, increasing near-term demand and firming export pricing dynamics.
• Stable acetic acid feedstock costs lowered production pressure, enabling manufacturers to maintain output and margins.
• Efficient port operations and inland logistics prevented delays, removing cost pressures, supporting steady export shipments.
Europe
• In Germany and major EU import hubs, the Magnesium Acetate Tetrahydrate Price Index rose by ~2.6% quarter-over-quarter, reflecting steady pharmaceutical procurement.
• The average Magnesium Acetate Tetrahydrate price for the quarter was approximately USD 1,060/MT for CFR Rotterdam imports (conservative regional estimate).
• Magnesium Acetate Tetrahydrate Spot Price firmed as European formulators began restocking and exporters trimmed discounts amid tighter spot availability.
• Magnesium Acetate Tetrahydrate Demand Outlook remains steady with pharmaceutical and nutraceutical offtake sustaining import volumes.
• Magnesium Acetate Tetrahydrate Production Cost Trend eased following softer acetic acid costs, reducing margin pressure on producers.
• Magnesium Acetate Tetrahydrate Price Forecast suggests a mild upward bias into Q4 as inventories draw down and seasonal procurement resumes.
• Balanced inventories, reliable port operations (Rotterdam/Hamburg) and regular import arrivals limited volatility while supporting firmer offers.
• Distributor restocking and steady export enquiries narrowed spot availability, contributing to the Price Index uptick.
Why did the price of Magnesium Acetate Tetrahydrate change in September 2025 in Europe?
• Restocking by pharmaceutical buyers reduced European inventories, tightening near-term availability and firming prices.
• Softer acetic acid feedstock costs eased production pressure, allowing producers to maintain run-rates without cutting offers.
• Efficient port logistics and predictable imports prevented delays and cost shocks, so price strength was driven mainly by demand/inventory dynamics.
For the Quarter Ending June 2025
Asia-Pacific (APAC)
• The Magnesium Acetate Tetrahydrate Spot Price in China fluctuated mildly across Q2 2025, registering a decline in April (-1.34%) and May (-0.97%), followed by a marginal recovery in June (+0.98%), reaching USD 1030/MT.
• The Price Index movement in June indicated a cautious upward shift driven by exporter margin protection, despite muted global inquiries and moderate downstream activity.
• Throughout the quarter, the Magnesium Acetate Tetrahydrate Production Cost Trend was stable due to a gradual decline in acetic acid feedstock prices, allowing producers to maintain cost-efficiency.
• Production conditions across Chinese facilities remained uninterrupted, with throughput levels aligning closely with real-time demand volumes, preventing market saturation.
• Inventory buildup was observed during May and June due to a delayed response from international buyers, especially from pharmaceutical clients holding back restocking decisions.
• The Magnesium Acetate Tetrahydrate Demand Outlook in China stayed neutral to slightly soft, with stable pharmaceutical off-take and non-aggressive buying from nutraceutical and food additive sectors.
• Despite monsoon onset in some regions, China experienced seamless logistics in Q2 2025, with no disruptions in port operations or inland movement, further stabilizing trade flow.
• Exporters adopted short-cycle pricing tactics to stay competitive while limiting exposure to long-dated contracts, reflecting their tactical approach amid a flat demand cycle.
• Why did the price change in July 2025?
Price Forecast for July 2025 suggests mild stability or a marginal increase as inventory normalizes and routine formulation procurement picks up ahead of seasonal uptick.
North America
• The Magnesium Acetate Tetrahydrate Spot Price in North America remained largely stable in Q2 2025, with no sharp movements due to aligned supply-demand ratios and contract-bound procurement from pharmaceutical manufacturers.
• The Price Index showed minimal fluctuations, reflecting subdued but consistent formulation demand and absence of major cost pressures or raw material constraints.
• The Magnesium Acetate Tetrahydrate Production Cost Trend remained neutral as U.S. producers benefited from steady access to domestic and imported acetic acid at controlled costs.
• Domestic production rates were balanced, with no signs of oversupply or capacity strain, helping suppliers meet steady contract volumes without pushing excess inventory into the spot market.
• Pharmaceutical demand remained consistent across Q2 due to uninterrupted formulation cycles and predictable orders from OTC and dermatological product manufacturers.
• The Magnesium Acetate Tetrahydrate Demand Outlook remained steady, aided by low-to-moderate growth in topical and supplement-based applications, although nutraceutical segment remained cautious.
• No logistical issues were observed; domestic freight costs were stable, and port entries for imported intermediate materials were processed without delays or cost surges.
• Suppliers focused on fulfilling quarterly contracts, minimizing exposure to spot market volatility while maintaining order visibility with legacy clients.
• Why did the price change in July 2025?
The Price Forecast for July 2025 suggests marginal upward correction as formulation cycles intensify ahead of the fall demand season and buffer inventory procurement begins.
Europe
• The Magnesium Acetate Tetrahydrate Spot Price in Europe saw slight downward pressure in April and May due to subdued pharmaceutical formulation activity and reduced spot-level buying.
• The Price Index indicated modest decline for Q2 2025, reflecting supplier discounts to maintain order volumes amidst slow movement in downstream therapeutic and dietary supplement sectors.
• The Magnesium Acetate Tetrahydrate Production Cost Trend remained flat across European plants due to localized sourcing efficiencies and controlled acetic acid input costs.
• European buyers showed reduced urgency in bulk procurement throughout the quarter, waiting for clearer price signals amid ongoing macroeconomic caution.
• Distributors reported adequate inventory carryovers from Q1, discouraging fresh spot market purchases and putting downward pressure on market pricing.
• The Magnesium Acetate Tetrahydrate Demand Outlook across Europe remained lukewarm as there were no significant institutional tenders or seasonal health supplement drives influencing consumption.
• Production activity in regional facilities was steady but output was moderated slightly to avoid overstocking, leading to manageable pipeline inventory throughout Q2.
• Logistics within the EU remained smooth with efficient containerized transport, although minor disruptions due to localized regulatory checks were noted in May.
• Why did the price change in July 2025?
The Price Forecast for July 2025 is slightly bullish as buyers will likely initiate fresh contracting before seasonal formulation peaks, leading to a cautious upward correction in the Spot Price.
For the Quarter Ending March 2025
North America
In the first quarter of 2025, the Magnesium Acetate Tetrahydrate market in North America showed a slightly mixed tone. There was no sharp movement in pricing, but mild pressure was seen from the buying side. Although figures showed limited fluctuation, market indicators suggest that price levels either held firm or showed a mild downward adjustment.
Procurement activity was cautious, with buyers sticking to planned orders. Demand from pharmaceuticals and personal care remained in place but was not aggressive. Many buyers were managing with existing inventories, so there was no urgency in the market. The overall sentiment stayed balanced, with no strong upward or downward push. Logistics were smooth, and seasonal transition across the region did not affect supply lines.
Although tariff measures remained in place, they did not exert any noticeable impact on the market during the quarter. Most suppliers adjusted their quotes based on available stock rather than any raw material pressure. Since Acetic Acid prices were steady, there was no cost-driven momentum in the market. The overall tone of Q1 remained quiet, shaped by routine trade and stable market behaviour across key segments.
Asia Pacific
In Asia Pacific, the average price of Magnesium Acetate Tetrahydrate declined by 1.23% during the first quarter of 2025. The fall was not steep, but it reflected a soft undertone in the market. The Chinese Lunar New Year fell in February, which affected production and shipments for a brief period. However, most suppliers had prepared in advance, and inventory levels were managed well. Procurement was planned, and buyers did not rush orders.
Demand from downstream sectors like pharmaceuticals, nutraceuticals, and food processing was steady but not strong. The seasonal shift in the region also played a role in maintaining subdued activity. Since Acetic Acid, a key raw material, remained price-stable during the quarter, there was no cost pressure seen from upstream. Suppliers kept their offers flexible, especially in March, to ensure steady offtake.
Logistic operations returned to normal after the holiday period and no major delays were seen in regional exports. Overall, the market was calm with soft demand and disciplined procurement, which led to a slight dip in average prices over the quarter.
Europe
In Europe, the Magnesium Acetate Tetrahydrate market showed little volatility during the first quarter of 2025. Prices appeared to be mostly stable with a soft inclination towards the lower side. The change was not sharp, but market feedback suggested slight easing in prices in some parts.
Demand from downstream industries like pharmaceuticals and food-grade applications stayed modest. Buyers did not place bulk orders and preferred to move with short-term requirements. Inventories were well maintained and helped avoid any sudden spot buying. With raw material costs like Acetic Acid holding stable, there was no push from the supply side either. The logistics network worked smoothly throughout the quarter. There were no reported delays in domestic or regional deliveries.
Market players maintained regular purchase activity, and sellers kept quotes consistent. A few traders offered slightly discounts to support movement, but the general price trend stayed flat to slightly soft. Overall, the quarter passed without any aggressive pricing action. Market sentiment stayed neutral and was guided more by regular trade flow than by cost or demand pressure.
